Updated analysis of CALGB (Alliance) 100104 assessing lenalidomide versus placebo maintenance after single autologous stem-cell transplantation for multiple myeloma: a randomised, double-blind, phase 3 trial
Titel:
Updated analysis of CALGB (Alliance) 100104 assessing lenalidomide versus placebo maintenance after single autologous stem-cell transplantation for multiple myeloma: a randomised, double-blind, phase 3 trial
Auteur:
Holstein, Sarah A Jung, Sin-Ho Richardson, Paul G Hofmeister, Craig C Hurd, David D Hassoun, Hani Giralt, Sergio Stadtmauer, Edward A Weisdorf, Daniel J Vij, Ravi Moreb, Jan S Callander, Natalie S van Besien, Koen Gentile, Teresa G Isola, Luis Maziarz, Richard T Bashey, Asad Landau, Heather Martin, Thomas Qazilbash, Muzaffar H Rodriguez, Cesar McClune, Brian Schlossman, Robert L Smith, Scott E Hars, Vera Owzar, Kouros Jiang, Chen Boyd, Molly Schultz, Chelsea Wilson, Marcia Hari, Parameswaran Pasquini, Marcelo C Horowitz, Mary M Shea, Thomas C Devine, Steven M Linker, Charles Anderson, Kenneth C McCarthy, Philip L